A prospective study of complications in newly diagnosed type 2 diabetes mellitus patients of lower socioeconomic group with special reference to microvascular complication and metabolic syndrome

K. Satya Anand; Ruksana .; Anand Acharya

doi:10.18203/2320-6012.ijrms20192503

Authors

K. Satya Anand Department of General Medicine, Konaseema Institute of Medical Science, Amalapuram, Andhra Pradesh, India
Ruksana . Department of General Medicine, Konaseema Institute of Medical Science, Amalapuram, Andhra Pradesh, India
Anand Acharya Department of Pharmacology, Konaseema Institute of Medical Science, Amalapuram, Andhra Pradesh, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20192503

Keywords:

Lower socioeconomic group, Microvascular complication, Metabolic syndrome, Type 2 diabetes mellitus

Abstract

Background: All these metabolic derangements exist for many years in the asymptomatic phase of type 2 diabetes and they predispose to development of complications even before clinical diagnosis. Metabolic syndrome is considered to be a precursor of type 2 diabetes. Present study is primarily aimed to study the prevalence of micro vascular complications and metabolic syndrome in newly diagnosed type 2 diabetes mellitus patients of low socio-economic group.

Methods: This is a cross sectional prospective study conducted in the dept. of general medicine Konaseema institute of medical science Amalapuram, Andhra Pradesh, India from November 2016 to October 2018. Based on exclusion and inclusion criteria 103 patients were enrolled for this study. Various parameters like age, sex, body mass index, waist circumference, lipid profile, systolic and diastolic blood pressure, neuropathy, nephropathy and retinopathy was measured.

Results: The mean age of the patient was 48±10.0 years. Fasting and 2 hours OGTT was 174.6±46.8 mg/dl and 255.6±75.6 mg/dl. The mean of total cholesterol was 204.7±41.9 (mg/dl), Triglycerides was 218±83.4 (mg/dl) and HDL was 44±5.3 (mg/dl). Symptomatic neuropathy constituted 35.6% in 51-60 age group and 27.1% in 31-40 and 41-50 age groups. Objective neuropathy constituted highest (36.6%) in 51-60 age group. Retinopathy constituted highest (60%) in 51-60 age group and nephropathy constituted 26.3 % in 21-30 and 51-60 age groups.

Conclusions: Prevalence of microvascular complications in newly diagnosed diabetics of low socioeconomic group were as follows: symptomatic neuropathy-57.3%, objective neuropathy-39.8%, retinopathy-4.9%, nephropathy-18.4%. These were similar to published studies from general population from the same geographical area.

Metrics

Metrics Loading ...

References

American Diabetic Association recommendations- Follow up report of the Expert committee on the Diagnosis and Classification of Diabetes mellitus. Diabetes Care. 2003;26:3160-67.

Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH, et al. Nephropathy in diabetes. Diabetes Care. 2004;27(1):S79-83.

Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-Tirgoviste C, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM complications study. Diabetologia. 1996;39(11):1377-84.

Koher EM. Diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol. 1998;116:297-303.

Rema M, Mohan V. Retinopathy at diagnosis among young Asian diabetic patients: the ASDIAB Study Group. Diabetes. 2002;51(2):A206-7.

Dowse GK, Humphrey AR, Collins VR, Plehwe W, Gareeboo H, Fareed D, et al. Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. American J Epidemiol. 1998;147(5):448-57.

Spijkerman AM, Dekker JM, Nijpels G, Adriaanse MC, Kostense PJ, Ruwaard D, et al. The Hoorn Screening Study. Microvascular complications attime of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practive. Diabetes Care. 2003;26:2604-8.

Koopman RJ, Mainous AG, Liszka HA, Colwell JA, Slate EH, Carnemolla MA, et al. Evidence of nephropathy and neuropathy in US adults with undiagnosed diabetes. Ann Fam Med. 2006;4:427-32.

Mohan V, Unnikrishnan R, Shobana S, Malavika M, Anjana RM, Sudha V. Are excess carbohydrates the main link to diabetes and its complications in Asians?. Indian J Med Res. 2018;148:531-8.

Collins VR, Dowse GK, Plehwe WE, Imo TT, Toelupe PM, Taylor HR, et al. High prevalence of diabetic retinopathy and nephropathy in Polynesians of Western Samoa. Diabetes Care. 995;18:1140-49.

Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, et al. On behalf of the UK prospective diabetes study group. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS36): Prospective observational study. Br Med J. 2000;321:412-19.

Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study. I. Investigative Ophthalmol Visual Sci. 2005;46(7):2328-33.

Robins SJ, Collins D, Wittes JT, Papademetriou V, Deedwania PC, Schaefer EJ, et al. Relation of Gemfibrozil treatment and lipid levels with major coronary events. JAMA. 2001;285:1585-91.